Easing Requirements for Minimal Risk Clinical Trials
Expediting clinical trials that post minimal risk is important to advance healthcare & drug development. In particular, easing the requirements for informed consent regarding trial participants- for minimal risk clinical trials- can help expedite the entire clinical development process and ultimately accelerate the overall regulatory approval process. Earlier the US FDA’s regulations allowed for exceptions […]
Easing Requirements for Minimal Risk Clinical Trials Read More »